The result is expert guidance, sustainable progress, and support that fits your life.
What documentation does my Part D plan need to approve the Bridge
Semaglutide starts working immediately after the first dose, as it begins mimicking the GLP-1 hormone
Retatrutide is a synthetic 39-amino acid acylated peptide designed as a triple agonist targeting the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
This means we do not know if they are safe or work well, and this can lead to safety concerns
Clinical trials show that patients combining GLP-1 therapy with structured eating patterns, adequate protein intake, and resistance training maintain 60-70% of their weight loss long-term